Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director Declaration

21st May 2015 18:10

RNS Number : 9875N
ABCAM Plc
21 May 2015
 



For immediate release

21 May 2015

ABCAM PLC

("Abcam" or "the Company")

Director Disclosure

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of protein research tools, makes the following disclosure pursuant to paragraph (g) (v) of Schedule Two of the AIM Rules for Companies.

 

KCP Youth, a charity upon which Sue Harris, a Director of the Company, served as chair of trustees, was placed into members' voluntary liquidation and was dissolved on 19 May 2015.

 

There are no other disclosures required in relation to paragraph (g) (v) of Schedule Two of the AIM Rules for Companies.

 

 

For further information please contact:

Abcam

+ 44 (0) 1223 696 000

Jeff Iliffe, Chief Financial Officer

Laura Taylor, Investor Relations Manager

J.P.Morgan Cazenove - Nominated Adviser & Joint Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Alex Bruce - Nominated Adviser

Peel Hunt LLP - Joint Corporate Broker

+ 44 (0) 20 7418 8900

Clare Terlouw / Jock Maxwell MacDonald - Corporate Broking

 

Notes to Editors

About Abcam

Abcam plc is a global leader in the supply of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.

Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services and multi-language support and sells to over 100 countries. The Company was founded in 1998, and now employs over 800 people. Abcam was admitted to AIM in 2005 (AIM: ABC).

To find out more, please visit www.abcam.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNEAXSFAEPSEFF

Related Shares:

ABC.L
FTSE 100 Latest
Value8,809.74
Change53.53